Marshmallow

Metadata

Approved Indications

German Commission E

• Irritation of the mucous membranes of the mouth and throat
• Dry irritating cough (trockener Reizhusten)
• Mild inflammation of the gastric mucosa

ESCOP

• Dry irritating cough
• Irritation of the mucous membranes of the mouth and throat
• Mild gastrointestinal complaints

EMA/HMPC

• Traditional use: Treatment of irritation of the mouth or throat and associated dry cough
• Traditional use: Symptomatic treatment of mild gastrointestinal discomfort
• Based on long-standing traditional use (not well-established use category)

Agreement/Disagreement Between Bodies

All three bodies are in very close agreement. The indication for dry irritative cough is consistent across all monographs. Commission E and ESCOP are nearly identical. EMA classifies as “traditional use,” reflecting the limited RCT evidence despite extensive historical use and sound pharmacological rationale.

Important distinction: Marshmallow is specifically indicated for dry, irritative cough (Reizhusten), NOT productive cough. This distinguishes it from most other herbs in this collection (ivy leaf, thyme, primrose) which target productive cough.

Conditions Treated

• Dry irritative cough (primary indication — unique in this collection)
• Pharyngeal/throat irritation
• Oral mucosal irritation/inflammation
• Laryngitis (supportive)
• Mild gastric mucosal inflammation
• Upper respiratory tract irritation associated with common cold

Mechanism of Action

1. Bio-adhesive Mucosal Protection (Primary Mechanism)

• Mucilage polysaccharides adhere to the epithelial mucosa, forming a protective viscous film
• This film:
  • Shields irritated nerve endings from mechanical and chemical stimuli
  • Reduces the cough reflex trigger (antitussive effect without central nervous system action)
  • Creates a barrier against microbial invasion
  • Provides a moist environment promoting tissue regeneration
• Immediate onset of effect — the protective film forms upon contact with mucosa
• This is a purely local/topical mechanism, not requiring systemic absorption

2. Anti-inflammatory

• Phytohustil and marshmallow root extract demonstrate anti-inflammatory effects on macrophages in vitro
• Reduction of pro-inflammatory mediators (TNF-alpha, IL-6)
• Anti-oxidative effects also demonstrated
• [Source: PMC 7090173, Frontiers in Pharmacology 2020]

3. Endothelial Cell Support

• Marshmallow root extract improves migratory capacity of endothelial cells in vitro
• Suggests tissue repair/regeneration support beyond simple mucosal coating
• [Source: PubMed 36569306]

Key Active Constituents

• Mucilage polysaccharides (5-25% of dry root weight):
  • Galacturorhamnans
  • Arabinans
  • Glucans
  • Arabinogalactans
• Flavonoids: Hypolaetin, isoscutellarein (and their glucosides)
• Phenolic acids: Caffeic acid derivatives
• Pectin
• Starch (35-40% of root)
• Asparagine

Pharmacological Distinction

Marshmallow works as a local/topical demulcent, not a systemic drug. This means:

• Onset of effect is rapid (within minutes of contact)
• No systemic absorption is required for the primary effect
• The mechanism is physical/biophysical rather than biochemical
• Bio-adhesion to mucosal surfaces is the key property
• Duration of effect depends on residence time on the mucosa

Clinical Evidence Summary

Observational Studies

Fasse et al. (2018) — Consumer Survey on Phytohustil

• Design: Two survey studies of consumers purchasing marshmallow root extract products
• Population: 822 consumers buying STW 42 lozenges or syrup for dry cough
• Duration: 7-day treatment period
• Results:
  • Both preparations showed good effect on symptomatic treatment of oral/pharyngeal irritation and associated dry cough
  • Very rapid onset of effects reported by consumers
  • Good tolerability
  • High user satisfaction
• Limitation: Observational survey, not placebo-controlled
• [Source: PubMed 30064132]

Preclinical/In Vitro Evidence

Dawid-Pac (2019) — Review

• Animal experimental studies and clinical trials confirmed efficacy of A. officinalis extracts as monotherapy for treating dry cough
• Combination of A. officinalis with other plant extracts increased efficacy
• [Source: PubMed 31770755, Complementary Medicine Research]

Pavin et al. (2020) — Anti-inflammatory Activity

• In vitro study on Phytohustil and marshmallow root extract
• Demonstrated anti-inflammatory and anti-oxidative effects on macrophages
• [Source: PMC 7090173]

Clinical Evidence Gaps

• No large, randomized, placebo-controlled trials identified for marshmallow monotherapy
• Evidence relies on traditional use documentation, consumer surveys, and preclinical studies
• The physical/demulcent mechanism is well-understood, which partially compensates for the limited clinical trial evidence
• Designing a placebo-controlled trial for a demulcent is methodologically challenging (taste and texture are difficult to blind)

European vs. US/Anglophone Consensus

Safety Profile

Contraindications

• Hypersensitivity to Althaea officinalis or other Malvaceae
• No other contraindications known

Drug Interactions

• Absorption delay: Mucilage may slow the absorption of other orally administered medications. General recommendation: take marshmallow at least 30-60 minutes before or after other medications.
• No specific drug interactions documented

Side Effects

• Very rare
• Minor gastrointestinal disturbance possible (very uncommon)
• Exceptionally good safety profile
• No significant adverse events reported in clinical use

Pregnancy and Lactation

• Pregnancy: No known concerns from traditional use. However, formal safety studies are lacking. Generally considered compatible with pregnancy at therapeutic doses.
• Lactation: No known concerns. Generally considered compatible.
• [UNCERTAIN: Formal safety assessment is incomplete, though centuries of traditional use without signals provides some reassurance]

Clinical Dosage

Marshmallow Root

Marshmallow Leaf

Preparation Notes

• Cold maceration is preferred for root preparations: Soak dried root in cold water for 30-90 minutes. Hot water degrades mucilage polysaccharides.
• Lozenges and syrups provide the best mucosal contact and are preferred delivery forms for cough
• For cough: Allow syrup or lozenge to coat the throat slowly; do not wash down immediately with water

Sources

• German Commission E Monograph: Althaeae radix
• ESCOP Monograph: Althaeae radix
• EMA/HMPC Assessment Report on Althaea officinalis L., radix
• Fasse et al. (2018). PubMed 30064132.
• Dawid-Pac (2019). Complementary Medicine Research, 27(3):174-183.
• Pavin et al. (2020). Frontiers in Pharmacology, PMC 7090173.
• Altmeyers Encyclopedia: Althaeae radix entry.
• WebMD: Marshmallow overview.
• Karger: Althaea officinalis review (2019).

Connections

• Compare demulcent mechanism with Plantain (Plantago lanceolata — also mucilage-based)
• Key clinical distinction: Marshmallow is for DRY cough; ivy leaf (Ivy Leaf) and thyme (Thyme) are for PRODUCTIVE cough